1. Stocks
    2. /
  2. Telix Pharmaceuticals (ASX: TLX)
    3. /

Telix Pharmaceuticals (ASX: TLX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Telix Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Telix Pharmaceuticals (ASX: TLX)
    Latest News

    A young man punches the air in delight as he reacts to great news on his mobile phone.
    Broker Notes

    Brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
    Share Market News

    5 things to watch on the ASX 200 on Friday

    | James Mickleboro

    Will the market end the week on a high? Let's find out.

    Read more »

    Man with a hand on his head looks at a red stock market chart showing a falling share price.
    Share Fallers

    Why Bank of Queensland, Core Lithium, Ramsay, and Telix shares are sinking today

    | James Mickleboro

    These shares are being hit hard by investors on Thursday. But why?

    Read more »

    A man wearing a white coat and glasses is wide-mouthed in surprise.
    Share Gainers

    Telix shares just crashed 24%! Here's why

    | Bernd Struben

    Telix shares are having a day to forget on Thursday. But why?

    Read more »

    a man leans back in his chair with his arms supporting his head as he smiles a satisfied smile while sitting at his desk with his laptop computer open in front of him.
    Broker Notes

    Brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    Man with rocket wings which have flames coming out of them.
    Broker Notes

    Why Telix shares could rocket 60%+

    | James Mickleboro

    Big returns could be on offer here according to analysts at Bell Potter.

    Read more »

    A mature-aged woman wearing goggles and a red cape, rides her bike along the beach looking victorious.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a historic day for the Australian stock market.

    Read more »

    A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
    Growth Shares

    3 excellent ASX 200 growth shares to buy and hold

    | James Mickleboro

    Analysts believe good things are coming for buyers of these shares.

    Read more »

    Happy shareholders clap and smile as they listen to a company earnings report.
    Growth Shares

    Top Australian stocks to buy right now with $5,000

    | James Mickleboro

    These shares are highly rated by analysts for a reason.

    Read more »

    A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
    Broker Notes

    These ASX 200 shares could rise 50% to 90%

    | James Mickleboro

    Analysts think market-beating returns could be on the cards for buyers of these shares.

    Read more »

    Happy man working on his laptop.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's what brokers are recommending as buys this week.

    Read more »

    A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
    Healthcare Shares

    Broker says Telix shares could surge 80% higher after selloff

    | James Mickleboro

    Let's see what Bell Potter has to say about this beaten down healthcare share.

    Read more »

    Frequently Asked Questions

    No, Telix does not pay dividends at this time. 

    Telix Pharmaceuticals Ltd listed on the ASX on 15 November 2017.

    TLX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Telix Pharmaceuticals

    Telix Pharmaceuticals Ltd (ASX: TLX) is a commercial-stage biopharmaceutical company focused on the ongoing development of diagnostic and therapeutic ('theranostic') products using targeted radiation. This process treats cancerous or diseased cells, an alternative approach to many cancer therapies which also attack healthy tissue at the same time.

    Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the US Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent Illuccix. It is working to get Illuccix approved for sale in the UK and Europe. 

    The company also has more than 20 clinical trials underway worldwide. Telix's research and development is focused on prostate, renal (kidney), glioblastoma (brain), and hematologic (bone marrow conditioning) cancers, as well as rare diseases. The company is headquartered in Australia with offices in Belgium, Japan, Switzerland, and the United States. 

    Profile

    since

    Note